Tiny Blue Dot Foundation
16
9
9
3
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
6.3%
1 terminated/withdrawn out of 16 trials
75.0%
-11.6% vs industry average
0%
0 trials in Phase 3/4
33%
1 of 3 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (16)
The ENHANCE Study: taVNS and Psilocybin
Role: collaborator
Transforming Adolescent Perception and Mental Health Through Meditation and Cognitive Reappraisal A Mixed Method Study
Role: collaborator
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study
Role: collaborator
Psilocybin for Prolonged Grief Disorder
Role: collaborator
Induction of Dreaming With EEG and Anesthesia in Healthy Adults
Role: collaborator
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 2
Role: collaborator
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
Role: collaborator
Sauna for Offline Connections and Interactive, Authentic Living
Role: collaborator
Induction of Dreaming With EEG and Anesthesia for Post-traumatic Stress Disorder
Role: collaborator
Feasibility of a Mental-Health Intervention Based on Contemplative Sleep Practices
Role: collaborator
Researching Heat and Yoga for Mood Enhancement
Role: collaborator
Investigation to Understand and Optimize Psilocybin
Role: collaborator
Consciousness, Psilocybin, and Well-Being
Role: collaborator
Investigating How the Brain Processes Different Experiences
Role: collaborator
The Use of LIFUP in Chronic Disorders of Consciousness
Role: collaborator
Thalamic Low Intensity Focused Ultrasound in Brain Injury
Role: collaborator
All 16 trials loaded